265 related articles for article (PubMed ID: 31667945)
1. Hepatitis B virus pregenomic RNA status can reveal the long-term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues.
Luo H; Tan N; Kang Q; Pan J; Chen H; Xi H; Yu M; Xu X
J Viral Hepat; 2020 Mar; 27(3):323-328. PubMed ID: 31667945
[TBL] [Abstract][Full Text] [Related]
2. Factors and virological significance of hepatitis B virus pregenomic RNA status after 5 years of antiviral therapy.
Pan J; Xu J; Luo H; Tan N; Kang Q; Chen H; Cheng R; Han Y; Yang Y; Xu X
Int J Infect Dis; 2021 Apr; 105():418-423. PubMed ID: 33676002
[TBL] [Abstract][Full Text] [Related]
3. [Serum hepatitis B virus pregenomic RNA profiles in patients with chronic hepatitis B on long-term antiviral therapy].
Pan JL; Luo H; Zhang XX; Han YF; Chen HY; Zeng Z; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2024 Jan; 32(1):16-21. PubMed ID: 38320786
[No Abstract] [Full Text] [Related]
4. Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B.
Laras A; Papatheodoridi M; Panopoulou E; Papatheodoridis GV; Hadziyannis SJ; Hadziyannis E
Virol J; 2022 Jan; 19(1):22. PubMed ID: 35093105
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues.
Liu S; Liu Z; Li W; Zhou B; Liang X; Fan R; Deng R; Hou J; Sun J
Aliment Pharmacol Ther; 2020 Aug; 52(4):692-700. PubMed ID: 32613672
[TBL] [Abstract][Full Text] [Related]
6. Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy.
Carey I; Gersch J; Wang B; Moigboi C; Kuhns M; Cloherty G; Dusheiko G; Agarwal K
Hepatology; 2020 Jul; 72(1):42-57. PubMed ID: 31701544
[TBL] [Abstract][Full Text] [Related]
7. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
[TBL] [Abstract][Full Text] [Related]
8. [Predictive Value of Baseline Serum Marker Levels for the Effect of Interferon Therapy in Patients With Chronic Hepatitis B].
Yan Y; Davgadorj C; Lyu C; Lu Z; Yu P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):383-390. PubMed ID: 38645851
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between serum HBV pgRNA and antigen status in patients with chronic hepatitis B after long-term nucleotide analogues treatment].
Rao X; Shi HH; Wu ZP; Li XP; Liu XY; Zhang LL
Zhonghua Gan Zang Bing Za Zhi; 2021 Aug; 29(8):766-770. PubMed ID: 34517458
[No Abstract] [Full Text] [Related]
10. Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative.
He D; Guo S; Chen W; Chen X; Yan G; Wang J; Li M; Zhu P; Huang H; Wang Y
BMC Infect Dis; 2013 Oct; 13():458. PubMed ID: 24090287
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection.
Butler EK; Gersch J; McNamara A; Luk KC; Holzmayer V; de Medina M; Schiff E; Kuhns M; Cloherty GA
Hepatology; 2018 Dec; 68(6):2106-2117. PubMed ID: 29734472
[TBL] [Abstract][Full Text] [Related]
13. Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).
Liem KS; Fung S; Wong DK; Yim C; Noureldin S; Chen J; Feld JJ; Hansen BE; Janssen HLA
Gut; 2019 Dec; 68(12):2206-2213. PubMed ID: 31462554
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.
Lin N; Ye A; Lin J; Liu C; Huang J; Fu Y; Wu S; Xu S; Wang L; Ou Q
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723011
[TBL] [Abstract][Full Text] [Related]
15. HBV/Pregenomic RNA Increases the Stemness and Promotes the Development of HBV-Related HCC Through Reciprocal Regulation With Insulin-Like Growth Factor 2 mRNA-Binding Protein 3.
Ding WB; Wang MC; Yu J; Huang G; Sun DP; Liu L; Zhang JN; Yang Y; Liu H; Zhou WP; Yang F; Yuan SX
Hepatology; 2021 Sep; 74(3):1480-1495. PubMed ID: 33825218
[TBL] [Abstract][Full Text] [Related]
16. HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre- and posttreatment: a multicentre observational cohort study.
Xu L; Li X; Lu L; Liu X; Song X; Li Y; Han Y; Zhu T; Cao W; Li T
J Viral Hepat; 2022 Aug; 29(8):616-626. PubMed ID: 35582838
[TBL] [Abstract][Full Text] [Related]
17. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
Lai CL; Wong D; Ip P; Kopaniszen M; Seto WK; Fung J; Huang FY; Lee B; Cullaro G; Chong CK; Wu R; Cheng C; Yuen J; Ngai V; Yuen MF
J Hepatol; 2017 Feb; 66(2):275-281. PubMed ID: 27639844
[TBL] [Abstract][Full Text] [Related]
18. Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients.
Wang ML; Liao J; Ye F; Tao YC; Wu DB; He M; Tang H; Chen EQ
J Med Virol; 2021 Jun; 93(6):3688-3696. PubMed ID: 32949174
[TBL] [Abstract][Full Text] [Related]
19. Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.
Ono A; Suzuki F; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Saitou S; Arase Y; Ikeda K; Kobayashi M; Watahiki S; Mineta R; Kumada H
J Hepatol; 2012 Sep; 57(3):508-14. PubMed ID: 22659518
[TBL] [Abstract][Full Text] [Related]
20. HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients.
Song G; Yang R; Jin Q; Liu J; Rao H; Feng B; Xie Y
BMC Gastroenterol; 2023 Nov; 23(1):381. PubMed ID: 37946120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
